Abstract
AbstractThe sensing of small molecules is important to a variety of fields and particularly to clinical diagnostics. Estriol is an important small chemical molecule, as it is one of three markers measured during mid‐gestation for the Down syndrome. Point‐of‐care testing of estriol will increase maternal compliance for aneuploidy mid‐gestation screening. A bioFET technology is a promising point‐of‐care platform. The meta‐nano‐channel (MNC) bioFET is employed with its tunable channel configuration to optimize the coupling between the electrostatics of the estriol‐receptor interactions and the electrodynamics of the conducting readout current. Also, the MNC bioFET receptor layer is composed of anti‐estriol antibodies to address the high structural similarity of estriol to other estrogens. Despite the small size and the electrical neutrality of estriol, real‐time is demonstrated, specific, and label‐free sensing of estriol in 0.5 µL of 1:100 diluted plasma with excellent linearity, sensitivity, dynamic range extending to ten orders of magnitude in estriol concentration and limit‐of‐detection of 1 fg mL−1. Extensive control and non‐specific measurements are reported including the response to other neutral members of the estrogen family.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
